(Q36283835)

13 August 2017

1 reference

title

Tailoring haemostatic treatment to patient requirements - an update on monitoring haemostatic response using thrombelastography (English)

1 reference

13 August 2017

1 reference

Sørensen B

1

1 reference

13 August 2017

Ingerslev J

series ordinal

2

1 reference

13 August 2017

publication date

1 November 2005

1 reference

13 August 2017

1 reference

13 August 2017

volume

11 Suppl 1

1 reference

13 August 2017

page(s)

1-6

1 reference

Whole blood coagulation thrombelastographic profiles employing minimal tissue factor activation

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2005.01156.X

The ability of three global plasma assays to recognize thrombophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2005.01156.X

Thrombin generation: phenotypic quantitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2005.01156.X

Control of bleeding in patients with haemophilia A with inhibitors: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2005.01156.X

Factor VIII inhibitor-bypassing agents act by inducing thrombin generation and can be monitored by a thrombin generation assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2005.01156.X

Whole blood clot formation phenotypes in hemophilia A and rare coagulation disorders. Patterns of response to recombinant factor VIIa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2005.01156.X

Thromboelastography and recombinant factor VIIa-hemophilia and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2005.01156.X

Reversal of the International Normalized Ratio with recombinant activated factor VII in central nervous system bleeding during warfarin thromboprophylaxis: clinical and biochemical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2005.01156.X

Thrombelastographic whole blood clot formation after ex vivo addition of plasma substitutes: improvements of the induced coagulopathy with fibrinogen concentrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2005.01156.X

Potential role of the dynamic properties of whole blood coagulation in assessment of dosage requirements in haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2005.01156.X

Impact of procoagulant concentration on rate, peak and total thrombin generation in a model system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2005.01156.X

10.1111/J.1365-2516.2005.01156.X

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference